Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,833,822
+$1,389,140 QoQ
Shares Held
35,105
+2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.18%
of 13F equity value
Holder Rank
#987
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETARY MANAGEMENT GROUP INC holds $39,611,391 across 9 Drug Manufacturers - General names. ABBV ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,775 | $17,721,579 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
35,105 | $8,833,822 | |
| 3 | AMGN |
Amgen Inc
|
13,171 | $4,769,482 | |
| 4 | JNJ |
Johnson & Johnson
|
17,045 | $4,328,918 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,685 | $2,015,522 | |
| 6 | PFE |
Pfizer Inc
|
38,004 | $915,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,850 | $798,037 | |
| 8 | NVS |
Novartis AG
|
1,259 | $197,310 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,833,822 | 35,105 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,444,682 | 34,230 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,821,212 | 34,230 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,188,412 | 35,365 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,750,071 | 36,365 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,629,670 | 36,415 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,506,485 | 36,615 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,210,982 | 36,515 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,460,300 | 37,665 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $6,788,870 | 37,281 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,844,693 | 37,715 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,583,042 | 37,455 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,969,212 | 44,305 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,973,281 | 50,030 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,976,261 | 49,355 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,808,473 | 50,730 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,823,412 | 51,080 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,361,633 | 51,580 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,051,632 | 52,080 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,315,833 | 49,280 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,937,011 | 43,830 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,748,693 | 43,880 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,897,290 | 45,705 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,016,439 | 45,855 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,637,041 | 47,230 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,619,025 | 47,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||